We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CEPF
626
Cantor Equity Partners IV
CEPF
$600M
$12.7M 0.02%
1,250,000
– –
GIS icon
627
General Mills
GIS
$19.2B
$12.7M 0.02%
341,096
-140,500
-29% -$6.1M
SKY icon
628
Champion Homes
SKY
$4.48B
$12.7M 0.02%
170,587
-162,413
-49% -$14M
DECK icon
629
Deckers Outdoor
DECK
$13.3B
$12.7M 0.02%
126,600
+35,000
+38% +$3.75M
BHVN icon
630
Biohaven
BHVN
$2.16B
$12.7M 0.02%
1,497,793
+1,347,793
+899% +$14.7M
IEX icon
631
IDEX
IEX
$16.5B
$12.7M 0.02%
66,786
-206,690
-76% -$40.8M
SLDB icon
632
Solid Biosciences
SLDB
$771M
$12.6M 0.02%
1,756,506
+356,506
+25% +$2.29M
NTST
633
NETSTREIT Corp
NTST
$2.16B
$12.6M 0.02%
670,000
– –
PAX icon
634
Patria Investments
PAX
$1.72B
$12.6M 0.02%
1,000,000
– –
VSH icon
635
Vishay Intertechnology
VSH
$5.86B
$12.6M 0.02%
+700,000
New +$12.7M
NDSN icon
636
Nordson
NDSN
$16.5B
$12.6M 0.02%
47,200
+29,000
+159% +$7.98M
WSM icon
637
Williams-Sonoma
WSM
$26.7B
$12.5M 0.02%
68,500
+2,500
+4% +$499K
VIA
638
Via Transportation Inc
VIA
$1.44B
$12.4M 0.02%
826,423
+476,423
+136% +$9.5M
LEN icon
639
Lennar Class A
LEN
$20.4B
$12.4M 0.02%
142,517
-52,300
-27% -$5.65M
ADAC
640
American Drive Acquisition Co
ADAC
$290M
$12.4M 0.02%
+1,250,000
New +$12.4M
LPCV
641
Launchpad Cadenza Acquisition Corp I
LPCV
$12.4M 0.02%
+1,250,000
New +$12.4M
EPRT icon
642
Essential Properties Realty Trust
EPRT
$6.99B
$12.1M 0.02%
400,000
-630,000
-61% -$20M
BLZR
643
Trailblazer Acquisition Corp
BLZR
$348M
$12.1M 0.02%
1,200,000
– –
ABUS icon
644
Arbutus Biopharma
ABUS
$865M
$12M 0.02%
2,664,941
-1,675,000
-39% -$7.32M
AA icon
645
Alcoa
AA
$11.7B
$11.9M 0.02%
+180,000
New +$11M
TKO icon
646
TKO Group
TKO
$13.5B
$11.9M 0.02%
59,100
-800
-1% -$164K
AVY icon
647
Avery Dennison
AVY
$12.3B
$11.9M 0.02%
69,000
+47,200
+217% +$8.67M
HBT icon
648
HBT Financial
HBT
$1.21B
$11.9M 0.02%
445,780
+188,201
+73% +$5.13M
EG icon
649
Everest Group
EG
$15.2B
$11.9M 0.02%
36,281
-1,600
-4% -$527K
DLTR icon
650
Dollar Tree
DLTR
$23.1B
$11.5M 0.02%
105,038
+18,800
+22% +$2.3M
24 25
26
27 28

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.